Azizi E, Galore G, Scope A, Pavlotsky F, Yakobson E,  Friedman E.
MC1R gene mutations in Jewish malignant melanoma patients.
Melanoma Res. 2006 Sep;16 (Supplement 1): S20

Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Cannon-Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis N, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang JM, Leachman S, Mackie RM, Magnusson V, Mann G, Newton-Bishop J, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Study Group LM, Genomel MG.
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents.
J Med Genet. 2006 Aug 11; [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16905682&query_hl=2&itool=pubmed_docsum

Hamama-Raz Y, Solomon Z, Schachter J, Azizi E.
Objective and subjective stressors and the psychological adjustment of melanoma survivors.
Psycho-oncology. 2006 Jul 20; [Epub ahead of print]

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16858669&query_hl=2&itool=pubmed_docsum

Vestin A, Weinstein J, Davidov E, Sidi Y, Yakobson EA.
Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
Eur J Hum Genet. 2000 Aug;8(8):590-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10951521&query_hl=22&itool=pubmed_docsum

Joanne C.Y. Loo, Andrew Paterson, AiHua Hao, Michael Shennan, Hava Peretz, Yechezkel Sidi, David Hogg, and Emanuel Yakobson.
The Search for Genetic Variants associated with Cutaneous Malignant Melanoma in the Ashkenazi Jewish Population.
J Med Genet. 42(5):e30, 2005

Marian Catalin, Alon Scope, Karine Laud, Eitan Friedman, Felix Pavlotsky, Emanuel Yakobson, Brigitte Bressac-de Paillerets, Esther Azizi.
Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish  melanoma families with or without neural system tumors.
Br J Cancer 92:2278-2285, 2005

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15928671&query_hl=23&itool=pubmed_docsum

Scope A, Friedman E, Azizi E.
A familial syndromic association between cutaneous malignant melanoma and neural system tumors [letter to Editor].
Br J Dermatol. 151:1278-1279, 2004.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15606533&query_hl=5&itool=pubmed_docsum

Yakobson E, Eisenberg S, Isacson R, Halle D, Levy-Lahad E, Catane R, Safro M, Sobolev V, Huot T, Peters G, Ruiz A, Malvehy J, Puig S, Chompret A, Avril MF, Shafir R, Peretz H, Bressac-de Paillerets B.
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
Eur J Hum Genet. 2003 Apr;11(4):288-96.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12700603&query_hl=13&itool=pubmed_docsum

Joanne C.Y. Loo, Andrew Paterson, AiHua Hao, Michael Shennan, Hava Peretz, Yechezkel Sidi, David Hogg, and Emanuel Yakobson.
The Search for Genetic Variants associated with Cutaneous Malignant Melanoma in the Ashkenazi Jewish Population.
2004 (submitted).

Baron-Epel O, Azizi E.
The association between counseling, sun protection, and early detection of skin cancer in middle-aged Israelis.
Cancer Detect Prev 27:338-344, 2003

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=14585320&query_hl=28&itool=pubmed_docsum

Grossman Z, Iscovich J, Schwartz F, Azizi E, Klepfish A, Schattner A, Sarid R.
Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8.
Mayo Clin Proc. 2002 Sep;77(9):905-9.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12233922&query_hl=20&itool=pubmed_docsum

Yakobson E. et al (2001)
Val59Gly CDKN2A germline mutation may be of the Mediterranean (Jewish?) origin.
Melanoma Research, 11, S69-70.

Yakobson E, Shemesh P, Azizi E, Winkler E, Lassam N, Hogg D, Brookes S, Peters G, Lotem M, Zlotogorski A, Landau M, Safro M, Shafir R, Friedman E, Peretz H.
Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
Eur J Hum Genet. 2000 Aug;8(8):590-6.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10951521&query_hl=22&itool=pubmed_docsum

Azizi E, Iscovich J, Pavlotsky F, Shafir R, Luria I, Federenko L, Fuchs Z, Milman V, Gur E, Farbstein H, Tal O.         
Use of sunscreen is linked with elevated naevi counts in Israeli school children and adolescents.
Melanoma Res. 2000 Oct;10(5):491-8.

Yakobson EA, Zlotogorski A, Shafir R, Cohen M, Icekson M, Landau M, Brenner S, Usher S, Peretz H.
Screening for tumour suppressor p16(CDKN2A) germline mutations in Israeli melanoma families.
Clin Chem Lab Med. 1998 Aug;36(8):645-8.

Yakobson E. et al (1998)
Germline p16 (CDKN2A) tumour suppressor alterations in Israeli melanoma families.
Cancer Detection and Prevention. 22, S-121.

Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E.
Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study.
AIDS. 1998 Oct 22;12(15):2067-72.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9814876&query_hl=26&itool=pubmed_docsum

Pavlotsky F, Azizi E, Gurvich R, Lusky A, Barell V, Weiner M, Iscovich J.         
Prevalence of melanocytic nevi and freckles in young Israeli males. Correlation with melanoma incidence in Jewish migrants: demographic and host factors.
Am J Epidemiol. 1997 Jul 1;146(1):78-86.

A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families

Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families

Page updated: 06/10/06